Rheumatology Doctors in Fremont, CA Accepting Medicare

6 Rheumatology doctors found. Showing 1 - 6

Sabiha Rasheed, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 734 Mowry Ave, Fremont, CA 94536 Phone: 510-792-3786    Fax: 510-792-4826

Dr. Barry Eiichi Shibuya, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3775 Beacon Ave, Suite 100, Fremont, CA 94538 Phone: 510-791-1300    Fax: 510-791-1301

Peter L. Hendler, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000

Naini Sharma, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 46047 Raindance Rd, Fremont, CA 94539 Phone: 510-793-3220

Vani Velkuru, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1999 Mowry Ave, Suite 2 - I, Fremont, CA 94538 Phone: 510-991-7508    Fax: 510-991-7503

Christine Nguyen Elias, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2333 Mowry Ave, Ste 300, Fremont, CA 94538 Phone: 510-796-0222    Fax: 510-796-7760

News Archive

Apixaban superior to enoxaparin in reducing venous thromboembolism in total knee replacement surgery patients

Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.

Discovery may lead to effective research and better treatments for  Ebola, other viral diseases

University of Alberta researchers have found the Ebola polymerase (enzyme), which may lead to more effective research and better treatments for the often fatal infection, and other related viral diseases.

Treatment-related heart failure risk for rheumatoid arthritis patients revealed

Rheumatoid arthritis patients have no greater risk for heart failure with tumor necrosis factor-alpha therapy than with nonbiologic disease-modifying antirheumatic drugs, research suggests.

Ruptured brain aneurysm treated through the nose

During breakfast one Sunday, Alfreda Cordero was struck suddenly and violently by the worst headache she had ever experienced. A day later, she would make medical history as the first person to have a ruptured brain aneurysm treated through the nose.

Read more Medical News

› Verified 8 days ago